IVLAV
CNTA

Index Venture Life Associates VI’s Centessa Pharmaceuticals CNTA Stock Holding History

Index Venture Life Associates VI’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396M Hold
9,961,789
– – 100% 1
2025
Q4 		$249M Hold
9,961,789
– – 100% 1
2025
Q3 		$242M Hold
9,961,789
– – 100% 1
2025
Q2 		$131M Hold
9,961,789
– – 100% 1
2025
Q1 		$143M Hold
9,961,789
– – 100% 1
2024
Q4 		$167M Buy
+9,961,789
New +$165M 99.89% 1
2022
Q3 		$40M Hold
9,961,789
– – 100% 1
2022
Q2 		$48.5M Hold
9,961,789
– – 100% 1
2022
Q1 		$89.4M Hold
9,961,789
– – 100% 1
2021
Q4 		$112M Buy
+9,961,789
New +$134M 100% 1

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Index Venture Life Associates VI's CNTA Position: Q1 2026 in Review

Index Venture Life Associates VI held its Centessa Pharmaceuticals (CNTA) position steady in Q1 2026 at 9,961,789 shares worth $396M. The position accounts for 100% of the portfolio, ranked #1.

Index Venture Life Associates VI first reported a position in CNTA in Q4 2021 and has held it in 10 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Index Venture Life Associates VI held 9,961,789 shares of Centessa Pharmaceuticals worth $396M as of Q1 2026.
  • Index Venture Life Associates VI left its Centessa Pharmaceuticals share count unchanged in Q1 2026.
  • Centessa Pharmaceuticals made up 100% of Index Venture Life Associates VI's portfolio in Q1 2026, its #1 holding.
  • Index Venture Life Associates VI first reported a position in Centessa Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Index Venture Life Associates VI's 13F filing for Q1 2026, filed 15 May 2026.